Company overview
biocrates life sciences provides mass spectrometry-based quantitative metabolomics kits and services, analyzing over 1,000 metabolites from more than 40 classes. Their ready-to-use kits enable reproducible quantification in biological samples for pharmaceutical R&D, biomarker discovery, and clinical research. The platform includes innovative software for sample preparation, data analysis, and metabolic phenotyping across applications like pharmacometabolomics, neurology, and nutrition.
Biocrates is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include metabolomics kits, quantitative metabolomics, biocrates, metabolite analysis, pharma r&d metabolomics.
Structured facts
- Website
- https://biocrates.com
- Markets served
- United States & Americas
- Keywords
- metabolomics kits, quantitative metabolomics, biocrates, metabolite analysis, pharma r&d metabolomics
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What metabolomics capabilities does biocrates offer?
- biocrates offers kits and assays for quantitative analysis of over 1,000 metabolites from more than 40 classes using mass spectrometry, with ready-to-use formats for sample preparation and data analysis.
- What are the key applications for biocrates kits in pharma R&D?
- Key applications include pharmacometabolomics, biomarker discovery, neurology, epidemiology, nutrition, microbiome research, and infectious diseases, supporting reproducible results in clinical studies.
- Does biocrates provide services or just kits?
- biocrates provides both ready-to-use metabolomics kits and metabolic phenotyping services for quality-controlled, quantitative analysis across the metabolic spectrum.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
